Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 3/20 | 0.41 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | ESRRA | P11474 | 1/20 | 0.37 |
| ▸ | PTGER1 | P34995 | 7/20 | 0.36 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.35 |
| ▸ | ACLY | P53396 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | AR | P10275 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13021504 | 0.88 | MAOB (0.46) | MAOBESRRACYP1A2CYP2C9 | |
| SCHEMBL25990439 | 0.84 | ESRRA (0.35) | MAOBNPC1RAB9AESRRACYP1A1 | |
| SCHEMBL21586945 | 0.84 | CYP1A1 (0.36) | ESRRACYP1A1CYP1A2CYP19A1 | |
| SCHEMBL21586947 | 0.83 | PDE2A (0.36) | NPC1RAB9ACYP1A2CYP2C9 | |
| SCHEMBL21586951 | 0.83 | PDE2A (0.35) | NPC1RAB9A | |
| SCHEMBL30887157 | 0.83 | PDE2A (0.36) | NPC1RAB9ACYP1A2CYP2C9 | |
| SCHEMBL23636566 | 0.83 | KDM4E (0.35) | MAOBNPC1RAB9AESRRACYP1A1 | |
| SCHEMBL12199840 | 0.82 | CA1 (0.48) | NPC1RAB9A | |
| SCHEMBL23645034 | 0.82 | NPC1 (0.44) | MAOBNPC1RAB9AESRRACYP1A2 | |
| SCHEMBL23636564 | 0.81 | ACSS2 (0.37) | ESRRACYP1A1CYP1A2CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3578550-B1 | NOVEL RED-SHIFTING BENZOTRIAZOLE UV ABSORBERS | EVERLIGHT CHEM IND CORP (TW) | 2023-08-16 | — | — | EP | disclosed |
| EP-3848357-B1 | REACTIVE BENZOTRIAZOLE UV ABSORBER AND USE THEREOF | EVERLIGHT CHEM IND CORP (TW) | 2023-01-18 | — | — | EP | disclosed |
| US-20210214321-A1 | NOVEL REACTIVE BENZOTRIAZOLE UV ABSORBER AND USE THEREOF | EVERLIGHT CHEMICAL INDUSTRIAL CORPORATION (TW) | 2021-07-15 | — | — | US | disclosed |
| EP-3848357-A1 | REACTIVE BENZOTRIAZOLE UV ABSORBER AND USE THEREOF | Everlight Chemical Industrial Corporation (TW) | 2021-07-14 | — | — | EP | disclosed |
| EP-3578550-A1 | NOVEL BENZOTRIAZOLE UV ABSORBER WITH RED SHIFT AND USE THEREOF | Everlight Chemical Industrial Corporation (TW) | 2019-12-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210214321-A1 | NOVEL REACTIVE BENZOTRIAZOLE UV ABSORBER AND USE THEREOF | SULT1A1, XDH, SULT2A1 | MAOB 237/4885HRH4 862/4885NPC1 4155/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.